poisar

Stock

Intensity Therapeutics, Inc. INTS

$4.42+0.00%

Overview

INTS market data

Price History

INTS price chart

Valuation & Profitability

no valuation data
No Valuation Data Yet

Alpha Vantage and Twelve Data both returned no valuation metrics for INTS. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.

Company news

1 captured
Intensity Therapeutics Administers New Patients With INT230‑6 In INVINCIBLE‑4 Switzerland Study; Trial Evaluates pCR Rates Vs Null Hypothesis Across SOC And INT230‑6+SOC CohortsBenzinga · Jul 15, 2026, 11:48 AM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock